Bhageria Industries FY26 revenue surges 46%, solar capacity hits 21 MW
Bhageria Industries Limited reported a 45.77% increase in standalone total income to ₹880.56 crore for FY2025-26, with net profit rising to ₹50.30 crore. The Board recommended a final dividend of ₹2.50 per share, while solar capacity expanded to 21 MW with the commissioning of new plants.

*this image is generated using AI for illustrative purposes only.
Bhageria Industries Limited has released its Integrated Annual Report for FY2025-26, reporting robust growth across its core business segments. On a standalone basis, the company achieved total income of ₹880.56 crore for the year ended March 31, 2026, compared to ₹604.07 crore in FY2024-25 — a growth of 45.77%. Net profit after tax rose to ₹50.30 crore from ₹42.27 crore in the previous year, while earnings per share improved to ₹11.52 from ₹9.68. The Board of Directors has recommended a final dividend of ₹2.50 per equity share of face value ₹5 each, representing a 50% dividend on the paid-up equity share capital and a payout of 21.69% of profits, subject to shareholder approval at the 37th Annual General Meeting scheduled for August 1, 2026.
Financial Performance Overview
The company's financial results for FY2025-26 reflect significant top-line expansion alongside steady profitability. The following table summarises the key standalone and consolidated financial metrics:
| Particulars: | Standalone FY2025-26 | Standalone FY2024-25 | Consolidated FY2025-26 | Consolidated FY2024-25 |
|---|---|---|---|---|
| Total Income (₹ Crore): | 880.56 | 604.07 | 880.79 | 601.59 |
| EBITDA (₹ Crore): | 102.25 | 90.82 | 98.00 | 88.40 |
| EBITDA Margin (%): | 11.61% | — | 11.26% | — |
| Profit After Tax (₹ Crore): | 50.30 | 42.27 | 44.49 | 38.69 |
| EPS (₹): | 11.52 | 9.68 | 10.56 | 9.26 |
| Revenue from Operations (₹ Crore): | 871.43 | 597.16 | 873.96 | 594.61 |
| Finance Cost (₹ Crore): | 2.11 | 1.63 | 3.42 | 2.79 |
| Depreciation & Amortisation (₹ Crore): | 32.28 | 31.42 | 32.62 | 31.42 |
| Profit Before Tax (₹ Crore): | 67.86 | 57.77 | 61.97 | 54.18 |
On a consolidated basis, total income grew to ₹880.79 crore from ₹601.59 crore, registering a growth of 46.41%. Consolidated EBITDA stood at ₹98.00 crore compared to ₹88.40 crore in FY2024-25, while consolidated PAT stood at ₹44.49 crore versus ₹38.69 crore in the prior year. The consolidated net worth as at March 31, 2026 stood at ₹456.53 crore.
Segment-wise Performance
The company operates across three primary business segments — Chemicals, Solar Power, and Pharmaceuticals. The Chemical segment was the dominant contributor to revenues in FY2025-26, as detailed below:
| Segment: | Standalone Revenue FY26 (₹ Crore) | Standalone Revenue FY25 (₹ Crore) | Standalone EBIT FY26 (₹ Crore) | Standalone EBIT FY25 (₹ Crore) |
|---|---|---|---|---|
| Chemicals: | 829.56 | 504.31 | 69.26 | 56.46 |
| Solar Power: | 26.86 | 27.83 | 11.57 | 12.04 |
| Pharma: | 4.20 | 8.12 | (5.49) | (5.64) |
On a consolidated basis, the Chemical segment turnover was ₹829.56 crore (FY25: ₹504.31 crore) with EBIT of ₹69.26 crore (FY25: ₹56.46 crore). Consolidated Solar Power turnover stood at ₹27.13 crore (FY25: ₹27.83 crore) with EBIT of ₹11.39 crore, while the Pharma segment reported consolidated turnover of ₹6.45 crore (FY25: ₹5.57 crore) with an EBIT of (₹7.54) crore. Plant utilisation in the Chemical segment held at 95–97% through much of the year, supported by sustained export demand from customers in Southeast Asia and Europe. The company also commenced production of Plasticizers — a new product — at its Tarapur facility during the year.
Solar Energy Expansion
On the renewable energy front, the company's subsidiary Rahuri Cleantech Private Limited successfully commissioned a 14 MW solar power plant during FY2025-26. An additional 7 MW was commissioned in May 2026, taking total installed capacity to 21 MW. This plant forms part of a larger 32 MW capacity build-out under Maharashtra's MSKVY 2.0 scheme. Separately, the company undertook development of a 2.25 MW DC Solar Power Plant at Tapi, Songadh, Gujarat, for self-captive consumption, which is currently under implementation.
Key Financial Ratios
The following standalone key financial ratios reflect the company's operational and financial position for FY2025-26:
| Ratio: | FY2025-26 | FY2024-25 |
|---|---|---|
| Debtors Turnover (times): | 5.07 | 3.50 |
| Inventory Turnover (times): | 13.65 | 9.17 |
| Interest Coverage Ratio (times): | 33.22 | 36.38 |
| Current Ratio (times): | 2.83 | 2.71 |
| Debt Equity Ratio (times): | 0.02 | 0.08 |
| Operating Profit Margin (%): | 17.76% | 28.73% |
| Net Profit Margin (%): | 5.77% | 7.08% |
| Return on Net Worth (%): | 11.48% | 10.63% |
The improvement in inventory and receivables turnover ratios reflects enhanced working capital management. The decline in the Debt-Equity Ratio was primarily on account of reduction in borrowings and improvement in net worth. The decline in Operating Profit Margin was attributable to changes in product mix, competitive market conditions, and higher input costs.
Corporate Governance and Board Matters
The Board of Directors comprises seven directors as on March 31, 2026 — three Executive Directors and four Independent Directors, including one Woman Director. The Board met four times during FY2025-26. At the forthcoming 37th AGM, members will consider the re-appointment of Mr. Suresh Bhageria as Executive Director & Chairman (WTD), Mr. Vinod Bhageria as Managing Director, and Mr. Vikas Bhageria as Jt. Managing Director, each for a period of three years commencing April 1, 2027 up to March 31, 2030. The remuneration of Cost Auditors M/s K V M & Co. at ₹2,00,000/- plus GST for FY2026-27 is also proposed for ratification.
The following table summarises the key AGM agenda items:
| AGM Item: | Details |
|---|---|
| AGM Date: | August 1, 2026, 12:30 p.m. IST (VC/OAVM) |
| Record Date: | July 24, 2026 |
| Book Closure: | July 25, 2026 to August 1, 2026 |
| Dividend Payment: | On or before August 31, 2026 |
| Re-appointment (Suresh Bhageria): | Executive Director & Chairman, April 1, 2027 to March 31, 2030 |
| Re-appointment (Vinod Bhageria): | Managing Director, April 1, 2027 to March 31, 2030 |
| Re-appointment (Vikas Bhageria): | Jt. Managing Director, April 1, 2027 to March 31, 2030 |
| Cost Auditor Remuneration: | ₹2,00,000/- plus GST for FY2026-27 |
During the year, the company completed the voluntary liquidation of its wholly owned subsidiary Bhageria Industries Holding Company WLL, incorporated in the Kingdom of Bahrain, with effect from November 20, 2025. As on March 31, 2026, the company has five subsidiary companies: Bhageria & Jajodia Pharmaceuticals Private Limited, Rahuri Cleantech Private Limited, Salasar Renewables Private Limited, Hikaru Solar Power Private Limited, and New Ahilyanagar Solar Private Limited.
Foreign Exchange and CSR
Foreign exchange earned during FY2025-26 stood at ₹30,371.92 lakhs, compared to ₹9,109.94 lakhs in FY2024-25. Foreign exchange outgo was ₹9,294.18 lakhs versus ₹9,295.99 lakhs in the prior year. On CSR, the company incurred expenditure of ₹33.99 lakhs during FY2025-26 against a statutory CSR obligation of ₹70.51 lakhs, utilising an eligible set-off balance of ₹280.51 lakhs arising from excess CSR expenditure incurred during FY2023-24 and FY2024-25. The company had 457 permanent employees on its rolls as on March 31, 2026.
Historical Stock Returns for Bhageria Industries
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -1.49% | 0.0% | -6.31% | +20.83% | +1.02% | -29.58% |
How will the commencement of Plasticizers production at the Tarapur facility contribute to revenue diversification and margin expansion in the coming fiscal year?
What is the expected timeline for the remaining 11 MW capacity under the MSKVY 2.0 scheme, and how will the completed 21 MW capacity impact the Solar Power segment's profitability?
With the Pharma segment reporting negative EBIT, does the company have a turnaround strategy or plans to restructure this loss-making vertical?































